Managing Complex Protocols in Ultra-Rare Disease Studies
Managing Complex Protocols in Ultra-Rare Disease Studies How to Effectively Manage Complex Protocols in Ultra-Rare Disease Clinical Trials Why Protocol Complexity is Unavoidable in Ultra-Rare Disease Trials Ultra-rare diseases—those affecting fewer than 1 in 50,000 individuals—pose immense challenges for clinical development. Due to limited scientific knowledge, lack of standardized endpoints, and heterogeneous patient presentations, protocols…
Read More “Managing Complex Protocols in Ultra-Rare Disease Studies” »